BCM
TECX

BML Capital Management’s Tectonic Therapeutic TECX Stock Holding History

BML Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-211,752
Closed -$6.42M – 30
2024
Q3 		$6.42M Sell
211,752
-254,295
-55% -$4.65M 3.78% 7
2024
Q2 		$7.68M Buy
466,047
+132,578
+40% +$2.12M 5.48% 6
2024
Q1 		$5.12M Hold
333,469
– – 3.38% 8
2023
Q4 		$5.44M Hold
333,469
– – 4.12% 7
2023
Q3 		$6.16M Buy
333,469
+312,113
+1,461% +$5.52M 5.66% 5
2023
Q2 		$243K Buy
+21,356
New +$241K 0.22% 27

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BML Capital Management's TECX Position: Q4 2024 in Review

BML Capital Management sold out of Tectonic Therapeutic (TECX) in Q4 2024, closing a stake of 211,752 shares — an estimated $6.42M sold.

BML Capital Management first reported a position in TECX in Q2 2023 and held it in 6 quarters. The position peaked at $7.68M in Q2 2024. 70 funds tracked by Wall St. Rank hold TECX as of Q4 2024.

  • BML Capital Management reported no remaining Tectonic Therapeutic position as of Q4 2024 after selling out during the quarter.
  • BML Capital Management sold 211,752 Tectonic Therapeutic shares in Q4 2024, an estimated $6.42M.
  • BML Capital Management first reported a position in Tectonic Therapeutic in Q2 2023 and held it in 6 quarters.
  • BML Capital Management's Tectonic Therapeutic position peaked at $7.68M in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2024.

Based on BML Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.